Business ❯ Pharmaceutical Industry

Research and Development

Clinical Research Cost Reduction Investment Innovation Clinical Trials Collaboration Market Trends Innovative Methods Corporate Expansion Technology Transfer Investment Trends Drug Discovery Partnerships Malaria Treatments Health Innovations Market Strategy Regulatory Compliance Investment in Health Sanofi Strategic Decisions Intellectual Property Product Launch

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

UBT251 targets GLP‑1, GIP plus glucagon for a mechanistically distinct approach to weight management.

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

FDA Issues Draft Guidance Easing Primate Tests for Some Antibody Drugs

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval